Delhi High Court Provides Relief To Mankind Pharma In Trademark Suit Against Sanshiv Health Tech

Delhi High Court Provides Relief To Mankind Pharma In Trademark Suit Against Sanshiv Health Tech

Notes that the pharmaceutical goods were formulated for children, hence required greater protection to avoid confusion

The Delhi High Court has granted injunctive relief to Mankind Pharma Limited by restraining a pharmaceutical manufacturer Sanshiv Health Tech from using a similar trademark.

The bench of Justice Saurabh Banerjee found that the defendant (Sanshiv) was guilty of blatantly adopting and using the impugned trade dress and design. On the other hand, the plaintiff (Mankind) made out a prima facie case for grant of an ad interim ex-parte injunction in its favor.

The judge ruled, "In case the defendants are not restrained by way of an ad interim ex-parte injunction, there is a likelihood of the plaintiff suffering irreparable harm, loss, injury and prejudice, which cannot be compensated in terms of money.”

The bench noted that the pharmaceutical goods were formulated specifically for children, therefore, greater protection was required to avoid confusion.

Mankind Pharma Limited was represented by Rajiv Nayar (Senior Advocate) along with the team of Khaitan & Co. It was led by Ankur Sangal (Partner), Ankit Arvind (Principal Associate), Shashwat Rakshit (Senior Associate) and Nidhi Pathak (Associate).